Formula: | C15H15ClN4O6S |
Molecular Weight: | 414.83 |
Rotatable Bond Donors: | 6 |
clogP: | 1.83 |
Topological Polar Surface Area: | 136.58 |
Lipinski's RO5: | MW: 414.83 HBA: 10 HBD: 2 RB: 6 LogP: 1.83 |
Rule of Three: | MW: 414.83 HBA: 10 HBD: 2 RB: 6 LogP: 1.83 |
|
DB |
---|
ZINC ID | Similarity | Structure | SDF |
---|
ZINC ID | Similarity | Structure | SDF | |
---|---|---|---|---|
ZINC900590 | 1.0 | ZINC900590 RDKit 3D 27 28 0 0 0 0 0 0 0 0999 V2000 5.8086 2.9349 0.9944 C 0 0 0 0 0 0 0 0 0 0 0 0 5.4370 1.5471 1.4537 C 0 0 0 0 0 0 0 0 0 0 0 0 4.6360 0.9496 0.4393 O 0 0 0 0 0 0 0 0 0 0 0 0 4.1308 -0.2307 0.8601 C 0 0 0 0 0 0 0 0 0 0 0 0 4.3677 -0.8085 1.9053 O 0 0 0 0 0 0 0 0 0 0 0 0 3.3108 -0.7905 -0.2220 C 0 0 0 0 0 0 0 0 0 0 0 0 3.6301 -2.0916 -0.6145 C 0 0 0 0 0 0 0 0 0 0 0 0 2.9627 -2.6853 -1.6832 C 0 0 0 0 0 0 0 0 0 0 0 0 1.9795 -1.9778 -2.3695 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6442 -0.6873 -1.9698 C 0 0 0 0 0 0 0 0 0 0 0 0 2.2994 -0.0991 -0.8883 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7446 1.4868 -0.3597 S 0 0 0 0 0 0 0 0 0 0 0 0 2.3653 2.4453 -1.2527 O 0 0 0 0 0 0 0 0 0 0 0 0 1.9058 1.5911 1.0759 O 0 0 0 0 0 0 0 0 0 0 0 0 0.0853 1.4898 -0.6779 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.7868 0.5630 -0.0640 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3618 -0.4105 0.5418 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.0973 0.8990 -0.2724 N 0 0 0 0 0 0 0 0 0 0 0 0 -3.1994 0.1416 0.1216 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.0465 -1.0723 0.6538 N 0 0 0 0 0 0 0 0 0 0 0 0 -4.1747 -1.7227 0.9903 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.9219 -3.2779 1.6675 Cl 0 0 0 0 0 0 0 0 0 0 0 0 -5.4485 -1.2514 0.8260 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.4874 -0.0030 0.2633 C 0 0 0 0 0 0 0 0 0 0 0 0 -6.7462 0.5272 0.0646 O 0 0 0 0 0 0 0 0 0 0 0 0 -6.6387 1.8268 -0.5036 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.3987 0.7064 -0.0989 N 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 1 0 3 4 1 0 4 5 2 0 4 6 1 0 6 7 2 0 7 8 1 0 8 9 2 0 9 10 1 0 10 11 2 0 11 12 1 0 12 13 2 0 12 14 2 0 12 15 1 0 15 16 1 0 16 17 2 0 16 18 1 0 18 19 1 0 19 20 2 0 20 21 1 0 21 22 1 0 21 23 2 0 23 24 1 0 24 25 1 0 25 26 1 0 24 27 2 0 11 6 1 0 27 19 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
Single dose inhibition of SARS-CoV-2 cytopathic effect in VeroE6 | primary assay | Organism Severe acute respiratory syndrome-related coronavirus | inactive |
Single dose inhibition of SARS-CoV-2 3CL-Pro | primary assay | Replicase polyprotein 1ab | inactive |